Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Utilization of cardiovascular medicines and cardiovascular mortality in Lithuania, Sweden and Norway in 2003-2012.

Lisauskienė I, Garuolienė K, Gulbinovič J.

Medicina (Kaunas). 2017 Jul 31. pii: S1010-660X(17)30052-6. doi: 10.1016/j.medici.2017.07.004. [Epub ahead of print]

2.

International trends in antipsychotic use: A study in 16 countries, 2005-2014.

Hálfdánarson Ó, Zoëga H, Aagaard L, Bernardo M, Brandt L, Fusté AC, Furu K, Garuoliené K, Hoffmann F, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, Litchfield M, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Pearson SA, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Skurtveit S, Verdoux H, Wang LJ, Yahni CZ, Bachmann CJ.

Eur Neuropsychopharmacol. 2017 Jul 27. pii: S0924-977X(17)30428-5. doi: 10.1016/j.euroneuro.2017.07.001. [Epub ahead of print]

PMID:
28755801
3.

International trends in clozapine use: a study in 17 countries.

Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, Coma Fusté A, Furu K, Garuoliené K, Hoffmann F, Hollingworth S, Huybrechts KF, Kalverdijk LJ, Kawakami K, Kieler H, Kinoshita T, López SC, Machado-Alba JE, Machado-Duque ME, Mahesri M, Nishtala PS, Piovani D, Reutfors J, Saastamoinen LK, Sato I, Schuiling-Veninga CCM, Shyu YC, Siskind D, Skurtveit S, Verdoux H, Wang LJ, Zara Yahni C, Zoëga H, Taylor D.

Acta Psychiatr Scand. 2017 Jul;136(1):37-51. doi: 10.1111/acps.12742. Epub 2017 May 14.

PMID:
28502099
4.

Utilisation of the ESMO-MCBS in practice of HTA.

Wild C, Grössmann N, Bonanno PV, Bucsics A, Furst J, Garuoliene K, Godman B, Gulbinovič J, Jones J, Pomorski MK, Emprechtinger R.

Ann Oncol. 2016 Nov;27(11):2134-2136. Epub 2016 Aug 8. No abstract available.

PMID:
27502718
5.

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Ermisch M, Bucsics A, Vella Bonanno P, Arickx F, Bybau A, Bochenek T, van de Casteele M, Diogene E, Fürst J, Garuolienė K, van der Graaff M, Gulbinovič J, Haycox A, Jones J, Joppi R, Laius O, Langner I, Martin AP, Markovic-Pekovic V, McCullagh L, Magnusson E, Nilsen E, Selke G, Sermet C, Simoens S, Sauermann R, Schuurman A, Ramos R, Vlahovic-Palcevski V, Zara C, Godman B.

Front Pharmacol. 2016 Sep 28;7:305. eCollection 2016.

6.

Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies.

Garuolienė K, Godman B, Gulbinovič J, Schiffers K, Wettermark B.

Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):149-52. doi: 10.1586/14737167.2016.1158649. Epub 2016 Mar 17. No abstract available.

PMID:
26914489
7.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovič J, Jan S, Joppi R, Kalaba M, Magnisson E, McCullagh L, Miikkulainen K, Ofierska-Sujkowska G, Pedersen HB, Selke G, Sermet C, Spillane S, Supian A, Truter I, Vlahović-Palčevski V, Vien LE, Vural EH, Wale J, Władysiuk M, Zeng W, Gustafsson LL.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380. Review.

PMID:
25487078
8.

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, Finlayson AE, Fürst J, Garuoliene K, Herholz H, Kalaba M, Laius O, Piessnegger J, Sermet C, Schwabe U, Vlahović-Palčevski VV, Markovic-Pekovic V, Vončina L, Malinowska K, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 17;5:106. doi: 10.3389/fphar.2014.00106. eCollection 2014. Review.

9.

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Godman B, Malmström RE, Diogene E, Jayathissa S, McTaggart S, Cars T, Alvarez-Madrazo S, Baumgärtel C, Brzezinska A, Bucsics A, Campbell S, Eriksson I, Finlayson A, Fürst J, Garuoliene K, Gutiérrez-Ibarluzea I, Hviding K, Herholz H, Joppi R, Kalaba M, Laius O, Malinowska K, Pedersen HB, Markovic-Pekovic V, Piessnegger J, Selke G, Sermet C, Spillane S, Tomek D, Vončina L, Vlahović-Palčevski V, Wale J, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2014 Jun 10;5:109. doi: 10.3389/fphar.2014.00109. eCollection 2014. Review.

10.

Personalizing health care: feasibility and future implications.

Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL.

BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. Review.

11.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013.

12.

European countries with small populations can obtain low prices for drugs: Lithuania as a case history.

Garuoliene K, Godman B, Gulbinovič J, Wettermark B, Haycox A.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):343-9. doi: 10.1586/erp.11.24.

PMID:
21671703
13.

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.

Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, McGinn D, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL.

Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):707-22. doi: 10.1586/erp.10.72.

PMID:
21155704
14.

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

Godman B, Shrank W, Wettermark B, Andersen M, Bishop I, Burkhardt T, Garuolienè K, Kalaba M, Laius O, Joppi R, Sermet C, Schwabe U, Teixeira I, Tulunay FC, Wendykowska K, Zara C, Gustafsson LL.

Pharmaceuticals (Basel). 2010 Aug 5;3(8):2470-2494. Review.

15.

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Adamski J, Godman B, Ofierska-Sujkowska G, Osińska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, Kalaba M, Gustafsson R, Garuolienè K, Haycox A, Garattini S, Gustafsson LL.

BMC Health Serv Res. 2010 Jun 7;10:153. doi: 10.1186/1472-6963-10-153. Review.

16.

Policies to enhance prescribing efficiency in europe: findings and future implications.

Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, Garuoliene K, Herholz H, Joppi R, Kalaba M, Laius O, Lonsdale J, Malmström RE, Martikainen JE, Samaluk V, Sermet C, Schwabe U, Teixeira I, Tilson L, Tulunay FC, Vlahović-Palčevski V, Wendykowska K, Wettermark B, Zara C, Gustafsson LL.

Front Pharmacol. 2011 Jan 7;1:141. doi: 10.3389/fphar.2010.00141. eCollection 2010.

Supplemental Content

Loading ...
Support Center